Skip to main content
TipRanks
Go Ultimate75% OFF

Compare El.En. S.p.A. (0RH2) vs. Competitors

1 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GB:0RH2El.En. S.p.A.EUR 16.41EUR 1.35B13.5042.45%Moderate BuyUnlock the GB:0RH2 analyst price target with TipRanks PremiumGB:0RH2Unlock the GB:0RH2 top-analyst price target with TipRanks Premium
IT:DIADiaSorin S.p.A.EUR 77.84EUR 4.28B24.2532.38%HoldUnlock the IT:DIA analyst price target with TipRanks PremiumGB:0RH2 vs IT:DIAUnlock the IT:DIA top-analyst price target with TipRanks Premium
IT:RECRecordati Industria Chimica e Farmaceutica SPAEUR 52.75EUR 10.89B20.694.56%―Unlock the IT:REC analyst price target with TipRanks PremiumGB:0RH2 vs IT:RECUnlock the IT:REC top-analyst price target with TipRanks Premium
IT:GHCGarofalo Health Care S.P.A.EUR 5.16EUR 465.06M28.29-2.46%Moderate BuyUnlock the IT:GHC analyst price target with TipRanks PremiumGB:0RH2 vs IT:GHCUnlock the IT:GHC top-analyst price target with TipRanks Premium
IT:GPIGPI SpAEUR 15.12EUR 435.51M26.53-3.57%Moderate BuyUnlock the IT:GPI analyst price target with TipRanks PremiumGB:0RH2 vs IT:GPIUnlock the IT:GPI top-analyst price target with TipRanks Premium
IT:IMDI.M.D. International Medical Devices S.P.A.EUR 1.07EUR 19.05M15.17-26.71%―Unlock the IT:IMD analyst price target with TipRanks PremiumGB:0RH2 vs IT:IMDUnlock the IT:IMD top-analyst price target with TipRanks Premium

Performance Comparison

-20%0%20%40%60%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GB:0RH2El.En. S.p.A.16.414.8942.45%
IT:DIADiaSorin S.p.A.77.8418.3030.74%
IT:RECRecordati Industria Chimica e Farmaceutica SPA52.753.346.76%
IT:GHCGarofalo Health Care S.P.A.5.16-0.10-1.99%
IT:GPIGPI SpA15.12-0.96-5.95%
IT:IMDI.M.D. International Medical Devices S.P.A.1.07-0.26-19.79%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts